Managers / Q2 2020 · view latest →
Spouting Rock Asset Management, LLC
CIK 0001771174 · 925 W. LANCASTER AVENUE, SUITE 250, BRYN MAWR, PA, 19010 · 610-788-2128
Summary
Spouting Rock Asset Management, LLC reported $210M in U.S.-listed holdings across 134 positions for Q2 2020.
Its largest position, AMZN, represents 7.9% of the portfolio.
Compared with Q1 2020, the fund opened 58 new positions and exited 73.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 81.0% · $170M
- REIT · 12.9% · $27M
- Other · 3.1% · $7M
- ADR · 2.3% · $5M
- ETP · 0.6% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ABBVABBVIE INC | NEW | +23.1K | 23.1K | +$2M | $2M |
| OPCHOPTION CARE HEALTH INC | NEW | +145.0K | 145.0K | +$2M | $2M |
| ATVIEURACTIVISION BLIZZARD INC | NEW | +25.0K | 25.0K | +$2M | $2M |
| ZSZSCALER INC | NEW | +16.2K | 16.2K | +$2M | $2M |
| LOVELOVESAC COMPANY | NEW | +64.9K | 64.9K | +$2M | $2M |
| VAPOTHERM INC | NEW | +41.5K | 41.5K | +$2M | $2M |
| TEVATEVA PHARMACEUTICAL INDS LTD | NEW | +134.6K | 134.6K | +$2M | $2M |
| CRWDCROWDSTRIKE HLDGS INC | NEW | +15.1K | 15.1K | +$2M | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2023 | $273M | 118 | Feb 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $313M | 152 | Nov 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $276M | 157 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $284M | 175 | May 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $135M | 140 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $130M | 142 | Nov 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $154M | 133 | Aug 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $120M | 56 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $128M | 59 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $201M | 101 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $326M | 204 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $323M | 207 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $316M | 173 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $209M | 134 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $210M | 134 | Aug 3, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $392M | 150 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.